Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices 29159

Place: Marriott Pooks Hill, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Philip Washko, Ph.D.,

DMD, Scientific Review Administrator, 45

Center Drive, Natcher Building, Rm. 4AN44F,

National Institutes of Health, Bethesda, MD

20892, (301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–48, R01 Reviews.

Date: July 17, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Hyatt Regency Hotel, 100

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Anna Sandberg, Ph.D.,

Scientific Review Administrator, National

Institute of Dental and Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (301) 594–3089.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–39, Applicant Interview–

P01.

Date: August 27–28, 2001.

Time: 8:30 a.m. 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20892.

Contact Person: H. George Hausch, Ph.D.,

Chief, 4500 Center Drive, Natcher Building,

Rm. 4AN44F, National Institutes of Health,

Bethesda, MD 20892, (301) 594–2372.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13339 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental and

Craniofacial Research; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: NIDCR Special Grants

Review Committee, Review of F32s, K grants

and R03s.

Date: June 21–22, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Pooks Hill Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Yujing Liu, Ph.D, MD,

Scientific Review Administrator, National

Institute of Dental & Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (301) 594–2372.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13340 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental and

Craniofacial Research; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Dental and

Craniofacial Research Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Advisory

Dental and Craniofacial Research Council

NIDCR June 2001 Council Meeting.

Date: June 12, 2001.

Open: 8:30 a.m. to 12:30 p.m.

Agenda: Scientific Presentations, Directors

Report, Council Business.

Place: Natcher Building, 45 Center Drive,

Conference Rooms E1/E2, Bethesda, MD

20892.

Closed: 12:30 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Natcher Building, 45 Center Drive,

Conference Rooms E1/E2, Bethesda, MD

20892.

Contact Person: Dushanka V. Kleinman,

DDS, Deputy Director, National Institute of

Dental & Craniofacial Res., National Institutes

of Health, 9000 Rockville Pike, 31/2C39,

Bethesda, MD 20892, (301) 496–9469.

Information is also available on the

Institute’s/Center’s home page:

www.nidcr.nih.gov/discover/nadrc/

index.htm, where an agenda and any

additional information for the meeting will

be posted when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13341 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

‘‘Configurable Gene-Chip Finds Genetic

Factors in Addiction’’.

Date: June 5, 2001.

Agenda: To reivew and evaluate contract

proposals.